The DOI matches its Crossref record; 160 of the 160 references it cites were found in a registry or an index.
Peroxisome proliferator-activated receptors and inflammation
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881
Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,625
The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., & Glass, C. K. (1998) · Nature · doi:10.1038/34178 · Cited by 3,525
Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
Issemann, I., & Green, S. (1990) · Nature · doi:10.1038/347645a0 · Cited by 3,519
The RXR heterodimers and orphan receptors
Mangelsdorf, D. J., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90200-7 · Cited by 3,158
Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism*
Desvergne, B., & Wahli, W. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.5.0380 · Cited by 3,086
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
Jiang, C., Ting, A. T., & Seed, B. (1998) · Nature · doi:10.1038/34184 · Cited by 2,899
mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.
Tontonoz, P., Hu, E., Graves, R. A., Budavari, A. I., & Spiegelman, B. M. (1994) · Genes & Development · doi:10.1101/gad.8.10.1224 · Cited by 2,181
PPARγ Is Required for the Differentiation of Adipose Tissue In Vivo and In Vitro
Rosen, E. D., Sarraf, P., Troy, A. E., Bradwin, G., Moore, K., Milstone, D. S., Spiegelman, B. M., & Mortensen, R. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80211-7 · Cited by 2,079
PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL
Tontonoz, P., Nagy, L., Alvarez, J. G. A., Thomazy, V. A., & Evans, R. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81575-5 · Cited by 1,797
Kliewer, S. A., Umesono, K., Noonan, D. J., Heyman, R. A., & Evans, R. M. (1992) · Nature · doi:10.1038/358771a0 · Cited by 1,741
Peroxisome proliferator–activated receptor α mediates the adaptive response to fasting
Kersten, S., Seydoux, J., Peters, J. M., Gonzalez, F. J., Desvergne, B., & Wahli, W. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6223 · Cited by 1,649
Kliewer, S. A., Forman, B. M., Blumberg, B., Ong, E. S., Borgmeyer, U., Mangelsdorf, D. J., Umesono, K., & Evans, R. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.7355 · Cited by 1,400
Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors
Dreyer, C., Krey, G., Keller, H., Givel, F., Helftenbein, G., & Wahli, W. (1992) · Cell · doi:10.1016/0092-8674(92)90031-7 · Cited by 1,376
The PPARα–leukotriene B4 pathway to inflammation control
Devchand, P. R., Keller, H., Peters, J. M., Vazquez, M., Gonzalez, F. J., & Wahli, W. (1996) · Nature · doi:10.1038/384039a0 · Cited by 1,345
Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators
Staels, B., Koenig, W., Habib, A., Merval, R., Lebret, M., Torra, I. P., Delerive, P., Fadel, A., Chinetti, G., Fruchart, J.-C., et al. (1998) · Nature · doi:10.1038/31701 · Cited by 1,134
Chawla, A., Barak, Y., Nagy, L., Liao, D., Tontonoz, P., & Evans, R. M. (2001) · Nature Medicine · doi:10.1038/83336 · Cited by 1,069
A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis
Yokomizo, T., Izumi, T., Chang, K., Takuwa, Y., & Shimizu, T. (1997) · Nature · doi:10.1038/42506 · Cited by 971
Chinetti, G., Fruchart, J.-C., & Staels, B. (2000) · Inflammation Research · doi:10.1007/s000110050622 · Cited by 954
Keller, H., Dreyer, C., Medin, J., Mahfoudi, A., Ozato, K., & Wahli, W. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.6.2160 · Cited by 948
Chinetti, G., Griglio, S., Antonucci, M., Torra, I. P., Delerive, P., Majd, Z., Fruchart, J.-C., Chapman, J., Najib, J., & Staels, B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.40.25573 · Cited by 903
Göttlicher, M., Widmark, E., Li, Q., & Gustafsson, J. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4653 · Cited by 857
Li, A. C., Brown, K. K., Silvestre, M. J., Willson, T. M., Palinski, W., & Glass, C. K. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10370 · Cited by 833
Pasceri, V., Chang, J., Willerson, J. T., & Yeh, E. T. H. (2001) · Circulation · doi:10.1161/01.cir.103.21.2531 · Cited by 831
Newby, A. C. (2005) · Physiological Reviews · doi:10.1152/physrev.00048.2003 · Cited by 817
Anti-inflammatory drugs and their mechanism of action
Vane, J. R., & Botting, R. M. (1998) · Inflammation Research · doi:10.1007/s000110050284 · Cited by 798
Peroxisome proliferator-activated receptors in inflammation control
Delerive, P., Fruchart, J., & Staels, B. (2001) · Journal of Endocrinology · doi:10.1677/joe.0.1690453 · Cited by 755
PPARs: therapeutic targets for metabolic disease
Berger, J. P., Akiyama, T. E., & Meinke, P. T. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.03.003 · Cited by 713
Liver X Receptor Signaling Pathways in Cardiovascular Disease
Tontonoz, P., & Mangelsdorf, D. J. (2003) · Molecular Endocrinology · doi:10.1210/me.2003-0061 · Cited by 633
Peters, J. M., Lee, S. S. T., Li, W., Ward, J. M., Gavrilova, O., Everett, C., Reitman, M. L., Hudson, L. D., & Gonzalez, F. J. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.14.5119-5128.2000 · Cited by 633
Inhibition of NF-kappaB/Rel induces apoptosis of murine B cells.
Wu, M., Lee, H., Bellas, R. E., Schauer, S. L., Arsura, M., Katz, D., FitzGerald, M. J., Rothstein, T. L., Sherr, D. H., & Sonenshein, G. E. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00845.x · Cited by 587
Barak, Y., Liao, D., He, W., Ong, E. S., Nelson, M. C., Olefsky, J. M., Boland, R., & Evans, R. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012610299 · Cited by 586
Transcriptional Repression of Atherogenic Inflammation: Modulation by PPARδ
Lee, C.-H., Chawla, A., Urbiztondo, N., Liao, D., Boisvert, W. A., & Evans, R. M. (2003) · Science · doi:10.1126/science.1087344 · Cited by 580
Li, A. C., Binder, C. J., Gutierrez, A., Brown, K. K., Plotkin, C. R., Pattison, J. W., Valledor, A. F., Davis, R. A., Willson, T. M., Witztum, J. L., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci18730 · Cited by 573
Gulick, T., Cresci, S., Caira, T., Moore, D. D., & Kelly, D. P. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.11012 · Cited by 560
Poynter, M. E., & Daynes, R. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32833 · Cited by 550
Sher, T., Yi, H. F., McBride, O. W., & Gonzalez, F. J. (1993) · Biochemistry · doi:10.1021/bi00072a015 · Cited by 519
The role of PPAR-γ in macrophage differentiation and cholesterol uptake
Moore, K. J., Rosen, E. D., Fitzgerald, M. L., Randow, F., Andersson, L. P., Altshuler, D., Milstone, D. S., Mortensen, R. M., Spiegelman, B. M., & Freeman, M. W. (2001) · Nature Medicine · doi:10.1038/83328 · Cited by 513
Xin, X., Yang, S., Kowalski, J., & Gerritsen, M. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.9116 · Cited by 513
Chemokines and atherosclerosis
Reape, T. J., & Groot, P. H. E. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00346-9 · Cited by 504
Delerive, P., Martin-Nizard, F., Chinetti, G., Trottein, F., Fruchart, J.-C., Najib, J., Duriez, P., & Staels, B. (1999) · Circulation Research · doi:10.1161/01.res.85.5.394 · Cited by 502
Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia.
Law, R. E., Meehan, W. P., Xi, X. P., Graf, K., Wuthrich, D. A., Coats, W., Faxon, D., & Hsueh, W. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118991 · Cited by 476
Clark, R. B., Bishop-Bailey, D., Estrada-Hernandez, T., Hla, T., Puddington, L., & Padula, S. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.3.1364 · Cited by 465
Self-citationGervois, P., Fruchart, J.-C., Delerive, P., & Staels, B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004045200 · Cited by 456
Expression and Function of PPARγ in Rat and Human Vascular Smooth Muscle Cells
Law, R. E., Goetze, S., Xi, X.-P., Jackson, S., Kawano, Y., Demer, L., Fishbein, M. C., Meehan, W. P., & Hsueh, W. A. (2000) · Circulation · doi:10.1161/01.cir.101.11.1311 · Cited by 442
Antineoplastic effects of peroxisome proliferatoractivated receptor γ agonists
Grommes, C., Landreth, G. E., & Heneka, M. T. (2004) · The Lancet Oncology · doi:10.1016/s1470-2045(04)01509-8 · Cited by 440
Bishop-Bailey, D., & Hla, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.17042 · Cited by 424
Self-citationImpaired expression of peroxisome proliferator-activated receptor γ in ulcerative colitis
Dubuquoy, L., Jansson, E. Å., Deeb, S., Rakotobe, S., Karoui, M., Colombel, J.-F., Auwerx, J., Pettersson, S., & Desreumaux, P. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00271-3 · Cited by 424
Berger, J., Leibowitz, M. D., Doebber, T. W., Elbrecht, A., Zhang, B., Zhou, G., Biswas, C., Cullinan, C. A., Hayes, N. S., Li, Y., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6718 · Cited by 410
Greene, M. E., Blumberg, B., McBride, O. W., Yi, H., Kronquist, K. E., Kwan, K. W., Hsieh, L., Greene, G. L., & Nimer, S. D. (1995) · Europe PMC (PubMed Central) · Cited by 399
Critical roles of PPARβ/δ in keratinocyte response to inflammation
Tan, N. S., Michalik, L., Noy, N., Yasmin, R., Pacot, C., Heim, M., Flühmann, B., Desvergne, B., & Wahli, W. (2001) · Genes & Development · doi:10.1101/gad.207501 · Cited by 398
Yang, X. Y., Wang, L. H., Chen, T., Hodge, D. R., Resau, J. H., DaSilva, L., & Farrar, W. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.7.4541 · Cited by 377
15-deoxy-Δ12,14-PGJ2 induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats
Kawahito, Y., Kondo, M., Tsubouchi, Y., Hashiramoto, A., Bishop-Bailey, D., Inoue, K.-I., Kohno, M., Yamada, R., Hla, T., & Sano, H. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9652 · Cited by 377
Self-citationBreidert, T., Callebert, J., Heneka, M. T., Landreth, G., Launay, J. M., & Hirsch, E. C. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00990.x · Cited by 373
Jackson, S. M., Parhami, F., Xi, X.-P., Berliner, J. A., Hsueh, W. A., Law, R. E., & Demer, L. L. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.9.2094 · Cited by 373
Cloning of a Protein That Mediates Transcriptional Effects of Fatty Acids in Preadipocytes
Amri, E.-Z., Bonino, F., Ailhaud, G., Abumrad, N. A., & Grimaldi, P. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.5.2367 · Cited by 368
Peroxisome proliferator‐activated receptors in the cardiovascular system
Bishop‐Bailey, D. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703149 · Cited by 363
Self-citationMarx, N., Bourcier, T., Sukhova, G. K., Libby, P., & Plutzky, J. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.3.546 · Cited by 362
WAYMAN, N. S., HATTORI, Y., MCDONALD, M. C., MOTA‐FILIPE, H., CUZZOCREA, S., PISANO, B., CHATTERJEE, P. K., & THIEMERMANN, C. (2002) · The FASEB Journal · doi:10.1096/fj.01-0793com · Cited by 361
IJpenberg, A., Jeannin, E., Wahli, W., & Desvergne, B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.32.20108 · Cited by 352
Zhu, Y., Qi, C., Jain, S., Rao, M. S., & Reddy, J. K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.41.25500 · Cited by 346
Chung, S. W., Kang, B. Y., Kim, S. H., Pak, Y. K., Cho, D., Trinchieri, G., & Kim, T. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002577200 · Cited by 338
Zhang, B. (1996) · Molecular Endocrinology · doi:10.1210/me.10.11.1457 · Cited by 332
Marx, N., Kehrle, B., Kohlhammer, K., Grüb, M., Koenig, W., Hombach, V., Libby, P., & Plutzky, J. (2002) · Circulation Research · doi:10.1161/01.res.0000014225.20727.8f · Cited by 331
Maddox, L., & Schwartz, D. A. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.103921 · Cited by 330
Thiazolidinediones block tumor necrosis factor-alpha-induced inhibition of insulin signaling.
Peraldi, P., Xu, M., & Spiegelman, B. M. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119715 · Cited by 314
Issemann, I., Prince, R. A., Tugwood, J. D., & Green, S. (1993) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0110037 · Cited by 307
Ricote, M., Huang, J. T., Welch, J. S., & Glass, C. K. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.66.5.733 · Cited by 304
Marx, N., Mach, F., Sauty, A., Leung, J. H., Sarafi, M. N., Ransohoff, R. M., Libby, P., Plutzky, J., & Luster, A. D. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6503 · Cited by 296
Yue, T.-L., Chen, J., Bao, W., Narayanan, P. K., Bril, A., Jiang, W., Lysko, P. G., Gu, J.-L., Boyce, R., Zimmerman, D. M., et al. (2001) · Circulation · doi:10.1161/hc4601.099403 · Cited by 295
Lee, H., Shi, W., Tontonoz, P., Wang, S., Subbanagounder, G., Hedrick, C. C., Hama, S., Borromeo, C., Evans, R. M., Berliner, J. A., et al. (2000) · Circulation Research · doi:10.1161/01.res.87.6.516 · Cited by 292
Ameshima, S., Golpon, H., Cool, C. D., Chan, D., Vandivier, R. W., Gardai, S. J., Wick, M., Nemenoff, R. A., Geraci, M. W., & Voelkel, N. F. (2003) · Circulation Research · doi:10.1161/01.res.0000073585.50092.14 · Cited by 292
Metabolic and Additional Vascular Effects of Thiazolidinediones
Martens, F. M. A. C., Visseren, F. L. J., Lemay, J., de Koning, E. J. P., & Rabelink, T. J. (2002) · Drugs · doi:10.2165/00003495-200262100-00004 · Cited by 291
Gonzalez, F. J., Peters, J. M., & Cattley, R. C. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.22.1702 · Cited by 290
Mukherjee, R., Jow, L., Noonan, D., & McDonnell, D. P. (1994) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(94)90089-2 · Cited by 270
Marx, N., Froehlich, J., Siam, L., Ittner, J., Wierse, G., Schmidt, A., Scharnagl, H., Hombach, V., & Koenig, W. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000054195.35121.5e · Cited by 257
The role of PPARs in atherosclerosis
Duval, C., Chinetti, G., Trottein, F., Fruchart, J.-C., & Staels, B. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02385-7 · Cited by 246
Woerly, G., Honda, K., Loyens, M., Papin, J.-P., Auwerx, J., Staels, B., Capron, M., & Dombrowicz, D. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021384 · Cited by 244
Colville-Nash, P. R., Qureshi, S. S., Willis, D., & Willoughby, D. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.2.978 · Cited by 241
Gosset, P., Charbonnier, A.-S., Delerive, P., Fontaine, J., Staels, B., Pestel, J., Tonnel, A., & Trottein, F. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(2001010)31:10<2857::aid-immu2857>3.0.co;2-x · Cited by 225
The Acute Phase Response Is Associated with Retinoid X Receptor Repression in Rodent Liver
Beigneux, A. P., Moser, A. H., Shigenaga, J. K., Grunfeld, C., & Feingold, K. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000953200 · Cited by 223
Deplanque, D., Gelé, P., Pétrault, O., Six, I., Furman, C., Bouly, M., Nion, S., Dupuis, B., Leys, D., Fruchart, J.-C., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-15-06264.2003 · Cited by 219
Endogenous PPARγ mediates anti-inflammatory activity in murine ischemia-reperfusion injury
Nakajima, A., Wada, K., Miki, H., Kubota, N., Nakajima, N., Terauchi, Y., Ohnishi, S., Saubermann, L. J., Kadowaki, T., Blumberg, R. S., et al. (2001) · Gastroenterology · doi:10.1053/gast.2001.21191 · Cited by 216
Marx, N., Imhof, A., Froehlich, J., Siam, L., Ittner, J., Wierse, G., Schmidt, A., Maerz, W., Hombach, V., & Koenig, W. (2003) · Circulation · doi:10.1161/01.cir.0000069272.06194.91 · Cited by 215
Zhu, Y., Qi, C., Calandra, C., Rao, M. S. R., & Reddy, J. K. (1996) · Europe PMC (PubMed Central) · Cited by 212
Natarajan, C., & Bright, J. J. (2002) · Genes & Immunity · doi:10.1038/sj.gene.6363832 · Cited by 208
Peroxisome Proliferator-Activated Receptor α Agonists as Therapy for Autoimmune Disease
Lovett-Racke, A. E., Hussain, R. Z., Northrop, S., Choy, J., Rocchini, A., Matthes, L., Chavis, J. A., Diab, A., Drew, P. D., & Racke, M. K. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.9.5790 · Cited by 207
BENAYOUN, L., LETUVE, S., DRUILHE, A., BOCZKOWSKI, J., DOMBRET, M.-C., MECHIGHEL, P., MEGRET, J., LESECHE, G., AUBIER, M., & PRETOLANI, M. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.8.2101070 · Cited by 204
Varo, N., Vicent, D., Libby, P., Nuzzo, R., Calle-Pascual, A. L., Bernal, M. R., Fernández-Cruz, A., Veves, A., Jarolim, P., Varo, J. J., et al. (2003) · Circulation · doi:10.1161/01.cir.0000074043.46437.44 · Cited by 202
Zingarelli, B., Sheehan, M., Hake, P. W., O’Connor, M., Denenberg, A., & Cook, J. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6827 · Cited by 199
Thieringer, R., Fenyk-Melody, J. E., Le Grand, C. B., Shelton, B. A., Detmers, P. A., Somers, E. P., Carbin, L., Moller, D. E., Wright, S. D., & Berger, J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.1046 · Cited by 193
Akbiyik, F., Ray, D. M., Gettings, K. F., Blumberg, N., Francis, C. W., & Phipps, R. P. (2004) · Blood · doi:10.1182/blood-2004-03-0926 · Cited by 191
Niino, M., Iwabuchi, K., Kikuchi, S., Ato, M., Morohashi, T., Ogata, A., Tashiro, K., & Onoé, K. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00285-5 · Cited by 188
Constitutive activation of NF-kappa B in an animal model of aging
Spencer, N. (1997) · International Immunology · doi:10.1093/intimm/9.10.1581 · Cited by 187
Satoh, H., Tsukamoto, K., Hashimoto, Y., Hashimoto, N., Togo, M., Hara, M., Maekawa, H., Isoo, N., Kimura, S., & Watanabe, T. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.0126 · Cited by 182
An open-label trial of the PPARgamma ligand rosiglitazone for active ulcerative colitis
Lewis, J. D., Lichtenstein, G. R., Stein, R. B., Deren, J. J., Judge, T. A., Fogt, F., Furth, E. E., Demissie, E. J., Hurd, L. B., Su, C. G., et al. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.05333.x · Cited by 181
Sheu, M. Y., Fowler, A. J., Kao, J., Schmuth, M., Fluhr, J. W., Man, M.-Q., Elias, P. M., Feingold, K. R., Schoonjans, K., & Auwerx, J. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01626.x · Cited by 177
Katayama, K., Wada, K., Nakajima, A., Mizuguchi, H., Hayakawa, T., Nakagawa, S., Kadowaki, T., Nagai, R., Kamisaki, Y., Blumberg, R. S., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00262-2 · Cited by 176
Khandoudi, N., Delerive, P., Berrebi-Bertrand, I., Buckingham, R. E., Staels, B., & Bril, A. (2002) · Diabetes · doi:10.2337/diabetes.51.5.1507 · Cited by 174
Rival, Y., Benéteau, N., Taillandier, T., Pezet, M., Dupont-Passelaigue, E., Patoiseau, J.-F., Junquéro, D., Colpaert, F. C., & Delhon, A. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01589-8 · Cited by 173
Jones, D. C., Ding, X., & Daynes, R. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106908200 · Cited by 169
Landreth, G. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00296-2 · Cited by 169
Cell-mediated immunity in atherosclerosis
Hansson, G. K. (1997) · Current Opinion in Lipidology · doi:10.1097/00041433-199710000-00009 · Cited by 167
Trifilieff, A., Bench, A., Hanley, M., Bayley, D., Campbell, E. M., & Whittaker, P. A. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705232 · Cited by 160
Faveeuw, C., Fougeray, S., Angeli, V., Fontaine, J., Chinetti, G., Gosset, P., Delerive, P., Maliszewski, C., Capron, M., Staels, B., et al. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02319-x · Cited by 158
Chen, F., Law, S. W. T., & O’Malley, B. W. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.2302 · Cited by 156
Gervois, P. P., Delannoy, S., Fadel, A., Dubois, G., Kosykh, V., Fruchart, J., Najïb, J., Laudet, V., & Staels, B. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.3.0248 · Cited by 156
Bishop‐Bailey, D., & Wray, J. A. (2003) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(03)00003-0 · Cited by 151
Self-citationWang, T., Chen, W., Lin, J., Chen, M.-F., & Lee, Y. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2003.10.022 · Cited by 151
Padilla, J., Kaur, K., Cao, H., Smith, T. J., & Phipps, R. P. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.12.6941 · Cited by 150
Feingold, K. R., Kim, M. S., Shigenaga, J. K., Moser, A., & Grünfeld, C. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00205.2003 · Cited by 148
PPAR‐gamma modulates allergic inflammation through up‐regulation of PTEN
Lee, K. S., Park, S. J., Hwang, P. H., Yi, H. K., Song, C. H., Chai, O. H., Kim, J., Lee, M. K., & Lee, Y. C. (2005) · The FASEB Journal · doi:10.1096/fj.04-3309fje · Cited by 135
Patel, H. J., Belvisi, M. G., Bishop‐Bailey, D., Yacoub, M. H., & Mitchell, J. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.5.2663 · Cited by 133
Self-citationVerreth, W., De Keyzer, D., Pelat, M., Verhamme, P., Ganame, J., Bielicki, J. K., Mertens, A., Quarck, R., Benhabilès, N., Marguerie, G., et al. (2004) · Circulation · doi:10.1161/01.cir.0000147614.85888.7a · Cited by 131
Ppars, metabolic disease and atherosclerosis
Fruchart, J., Staels, B., & Duriez, P. (2001) · Pharmacological Research · doi:10.1006/phrs.2001.0871 · Cited by 129
Setoguchi, K., Misaki, Y., Terauchi, Y., Yamauchi, T., Kawahata, K., Kadowaki, T., & Yamamoto, K. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13202 · Cited by 125
Cuzzocrea, S., Wayman, N. S., Mazzon, E., Dugo, L., Paola, R. D., Serraino, I., Britti, D., Chatterjee, P. K., Caputi, A. P., & Thiemermann, C. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.5.997 · Cited by 124
Human B Lymphocytes and B Lymphomas Express PPAR-γ and Are Killed by PPAR-γ Agonists
Padilla, J., Leung, E., & Phipps, R. P. (2002) · Clinical Immunology · doi:10.1006/clim.2001.5181 · Cited by 123
Szántó, A., Benkő, S., Szatmári, I., Bálint, B. L., Furtos, I., Rühl, R., Molnar, S., Csiba, L., Garuti, R., Calandra, S., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.18.8154-8166.2004 · Cited by 118
Role of Peroxisome Proliferator‐Activated Receptors in Inflammation Control
Youssef, J., & Badr, M. Z. (2004) · BioMed Research International · doi:10.1155/s1110724304308065 · Cited by 112
Chinetti, G., Fruchart, J., & Staels, B. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802499 · Cited by 111
Okada, M., Yan, S. F., & Pinsky, D. J. (2002) · The FASEB Journal · doi:10.1096/fj.02-0503com · Cited by 108
PPARδ Functions as a Prostacyclin Receptor in Blastocyst Implantation
Lim, H. J., & Dey, S. K. (2000) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(00)00243-5 · Cited by 101
Cuzzocrea, S., Paola, R. D., Mazzon, E., Genovese, T., Muià, C., Centorrino, T., & Caputi, A. P. (2004) · Laboratory Investigation · doi:10.1038/labinvest.3700185 · Cited by 98
WY14,643, a PPARα Ligand, Has Profound Effects on Immune Responses In Vivo
Cunard, R. A., DiCampli, D., Archer, D. C., Stevenson, J. L., Ricote, M., Glass, C. K., & Kelly, C. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.12.6806 · Cited by 96
Martin‐Nizard, F., Furman, C., Delerive, P., Kandoussi, A., Fruchart, J., Staels, B., & Duriez, P. (2002) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200212000-00003 · Cited by 90
PPAR‐γ agonists as therapy for diseases involving airway neutrophilia
Birrell, M. A., Patel, H. J., McCluskie, K., Wong, S. M., Leonard, T. B., Yacoub, M. H., & Belvisi, M. G. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00098303 · Cited by 90
PPAR delta: an uncompletely known nuclear receptor
Fredenrich, A., & Grimaldi, P. A. (2005) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70162-3 · Cited by 86
Murao, K., Imachi, H., Momoi, A., Sayo, Y., Hosokawa, H., Sato, M., Ishida, T., & Takahara, J. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00765-6 · Cited by 85
Hill, M., Clarke, S. L., Rodgers, K., Thornhill, B., Peters, J. M., Gonzalez, F. J., & Gimble, J. M. (1999) · Infection and Immunity · doi:10.1128/iai.67.7.3488-3493.1999 · Cited by 81
Hu, Z., Kerb, R., Shi, X., Wei-Lavery, T., & Hoffman, B. B. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.037705 · Cited by 80
Ji, J. D., Cheon, H., Jun, J. B., Choi, S. J., Kim, Y. R., Lee, Y. H., Kim, T., Chae, I. J., Song, G. G., Yoo, D., et al. (2001) · Journal of Autoimmunity · doi:10.1006/jaut.2001.0542 · Cited by 74
Rosenbaum, S. E., & Greenberg, A. S. (1998) · Molecular Endocrinology · doi:10.1210/mend.12.8.0151 · Cited by 71
Bell, A. R., Savory, R., Horley, N., Choudhury, A. I., Dickins, M., Gray, T. J. B., Salter, A. M., & Bell, D. (1998) · Biochemical Journal · doi:10.1042/bj3320689 · Cited by 67
Wang, G., Wei, J., Guan, Y., Jin, N., Mao, J., & Wang, X. (2005) · Metabolism · doi:10.1016/j.metabol.2004.11.017 · Cited by 67
Voytovich, M. H., Simonsen, C., Jenssen, T. G., Hjelmesaeth, J. S., Åsberg, A., & Hartmann, A. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh641 · Cited by 64
Cuzzocrea, S., Pisano, B., Dugo, L., Ianaro, A., Britti, D., Patel, N. S. A., Paola, R. D., Genovese, T., Rosa, M. D., Caputi, A. P., et al. (2004) · Intensive Care Medicine · doi:10.1007/s00134-004-2180-1 · Cited by 60
Bishop‐Bailey, D., Hla, T., & Warner, T. D. (2002) · Circulation Research · doi:10.1161/01.res.0000029080.15742.85 · Cited by 59
Self-citationOkopień, B., Krysiak, R. G., Kowalski, J., Madej, A., Belowski, D., Zieliński, M., Łabuzek, K., & Herman, Z. S. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.05.009 · Cited by 58
I. PPARγ in the gastrointestinal tract: gain or pain?
Auwerx, J. H. (2002) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00508.2001 · Cited by 57
Peroxisome Proliferator-Activated Receptor Agonists Inhibit Inflammatory Edema and Hyperalgesia
Taylor, B. K., Dadia, N., Yang, C. B., Krishnan, S., & Badr, M. Z. (2002) · Inflammation · doi:10.1023/a:1015500531113 · Cited by 53
Expression and cDNA cloning of porcine peroxisome proliferator-activated receptor gamma (PPARγ)
Houseknecht, K. L., Bidwell, C. A., Portocarrero, C. P., & Spurlock, M. E. (1998) · Gene · doi:10.1016/s0378-1119(98)00533-2 · Cited by 52
Gervois, P. P., Fruchart, J., & Staels, B. (2004) · International Journal of Clinical Practice · doi:10.1111/j.1368-504x.2004.00376.x · Cited by 48
Endothelial cells, fibroblasts and vasculitis
Buckley, C. D., Rainger, G. E., Nash, G. B., & Raza, K. (2005) · Rheumatology · doi:10.1093/rheumatology/keh542 · Cited by 47
Dual Function of Troglitazone in ICAM-1 Gene Expression in Human Vascular Endothelium
Chen, N.-G., & Han, X. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4628 · Cited by 45
Peroxisome proliferator-activated receptors gamma ligands and ischemia and reperfusion injury
Cuzzocrea, S. (2004) · Vascular Pharmacology · doi:10.1016/j.vph.2004.10.004 · Cited by 44
Schmidt, A., Vogel, R. L., Witherup, K. M., Rutledge, S. J., Pitzenberger, S. M., Adam, M., & Rodan, G. A. (1996) · Lipids · doi:10.1007/bf02524285 · Cited by 44
Katsuki, A., Sumida, Y., Murata, K., Furuta, M., Araki-Sasaki, R., Tsuchihashi, K., Hori, Y., Yano, Y., Gabazza, E. C., & Adachi, Y. (2000) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2000.00072.x · Cited by 43
Hahmann, H., Bunte, T., Hellwig, N., et al. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90167-j · Cited by 42
Dietary n − 3 fatty acids accelerate catabolism of leukotriene B4 in human granulocytes
von Schacky, C., Kiefl, R., Marcus, A. J., Broekman, M. J., & Kaminski, W. E. (1993) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(93)90278-h · Cited by 39
The Role of NF-κB as a Survival Factor in Environmental Chemical-Induced Pre-B Cell Apoptosis
Mann, K. K., Doerre, S., Schlezinger, J. J., Sherr, D. H., & Quadri, S. A. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12841-6 · Cited by 34
Koh, K. K., Ahn, J. Y., Jin, D., Han, S. H., Kim, H. S., Choi, I. S., Ahn, T. H., Shin, E. K., & Jeong, E.-M. (2004) · International Journal of Cardiology · doi:10.1016/j.ijcard.2003.09.007 · Cited by 33
Benson, S., Padmanabhan, S., Kurtz, T. W., & Pershadsingh, H. A. (2000) · Molecular Cell Biology Research Communications · doi:10.1006/mcbr.2000.0209 · Cited by 29
Hotta, K., Gustafson, T. A., Yoshioka, S., Ortmeyer, H. K., Bodkin, N. L., & Hansen, B. (1998) · International Journal of Obesity · doi:10.1038/sj.ijo.0800718 · Cited by 29
Empen, K., Frost, R., Geiss, H., Otto, C., & Parhofer, K. (2003) · Cardiovascular Diabetology · doi:10.1186/1475-2840-2-17 · Cited by 22
Ryoo, S., Won, M., Kim, D.-U., Kim, L., Han, G., Park, S.-K., Mukaida, N., Maeng, P. J., Yoo, H., & Hoe, K. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.04.031 · Cited by 18
Momoi, A., Murao, K., Imachi, H., Sayo, Y., Nakamura, H., Hosokawa, H., Sato, M., Fujita, J., Okada, H., Ishida, T., et al. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00678-x · Cited by 16
Yang, Q., & Gonzalez, F. J. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.08.016 · Cited by 14
Couve, A., Koenig, C. S., & Santos, M. J. (1992) · Experimental Cell Research · doi:10.1016/0014-4827(92)90109-l · Cited by 13
Okapcová, J., & Gábor, D. (2004) · Angiology · doi:10.1177/00033197040550i604 · Cited by 13
Cited by
(1998) · PubMed · Cited by 2,737
Kauppinen, A., Suuronen, T., Ojala, J., Kaarniranta, K., & Salminen, A. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.06.007 · Cited by 989
Yan, Y., Jiang, W., Spinetti, T., Tardivel, A., Castillo, R., Bourquin, C., Guarda, G., Tian, Z., Tschopp, J., & Zhou, R. (2013) · Immunity · doi:10.1016/j.immuni.2013.05.015 · Cited by 784
“Although some reports propose other targets for u-3 FAs, such as TNF-a and PPAR-g (Moraes et al., 2006; Oh et al., 2010), our data support a key role for the inhibition of the NLRP3 inflammasome underlying the beneficial effect of u-3 FAs in inflammatory disorders, at least in the model of T2D we explored.”
BackgroundModulation of inflammation in brain: A matter of fat
Farooqui, A. A., Horrocks, L. A., & Farooqui, T. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04371.x · Cited by 460
The Bioactivity and Toxicological Actions of Carvacrol
Suntres, Z. E., Coccimiglio, J., & Alipour, M. (2015) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2011.653458 · Cited by 452
Metadata
- Authors
- Moraes, L. A., Piqueras, L., & Bishop-Bailey, D.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2006-06
- Volume
- 110
- Issue
- 3
- Pages
- 371-385
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2057505049
- Cited by
- 376
- References
- 160
- FWCI
- 6.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.